Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Takafumi Yokota
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan; Corresponding author
Yusuke Satoh
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan; Department of Lifestyle Studies, Kobe Shoin Women’s University, Kobe, Japan
Daisuke Okuzaki
DNA-chip Development Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Suita, Japan
Masahiro Tokunaga
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Tomohiko Ishibashi
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan; Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan
Takao Sudo
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan; Department of Immunology and Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan
Tomoaki Ueda
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Yasuhiro Shingai
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Michiko Ichii
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Akira Tanimura
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Sachiko Ezoe
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Hirohiko Shibayama
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Terumi Kohwi-Shigematsu
Department of Orofacial Sciences, University of California, San Francisco, San Francisco, CA, USA
Junji Takeda
Department of Genome Biology Graduate School of Medicine, Osaka University Graduate School of Medicine, Suita, Japan
Kenji Oritani
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Yuzuru Kanakura
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Summary: Hematopoietic stem cells (HSCs) comprise a heterogeneous population exhibiting self-renewal and differentiation capabilities; however, the mechanisms involved in maintaining this heterogeneity remain unclear. Here, we show that SATB1 is involved in regulating HSC heterogeneity. Results in conditional Satb1-knockout mice revealed that SATB1 was important for the self-renewal and lymphopoiesis of adult HSCs. Additionally, HSCs from Satb1/Tomato-knockin reporter mice were classified based on SATB1/Tomato intensity, with transplantation experiments revealing stronger differentiation toward the lymphocytic lineage along with high SATB1 levels, whereas SATB1− HSCs followed the myeloid lineage in agreement with genome-wide transcription and cell culture studies. Importantly, SATB1− and SATB1+ HSC populations were interconvertible upon transplantation, with SATB1+ HSCs showing higher reconstituting and lymphopoietic potentials in primary recipients relative to SATB1− HSCs, whereas both HSCs exhibited equally efficient reconstituted lympho-hematopoiesis in secondary recipients. These results suggest that SATB1 levels regulate the maintenance of HSC multipotency, with variations contributing to HSC heterogeneity. : Doi et al. show that hematopoietic stem cells (HSCs) with robust lymphopoietic and long-term reconstituting capability express special AT-rich sequence-binding protein 1 (SATB1). SATB1-expressing and non-expressing HSCs are interconvertible. Moreover, they provide insights into the heterogeneity of HSCs, which are correlated with changes in SATB1 expression levels. Keywords: hematopoietic stem cells, SATB1, lineage bias, heterogeneity, genetic fluctuation, self-renewal, multipotency, lymphopoiesis